SHW CEO receives 47,630 stock options; vesting starts Oct 2026
Rhea-AI Filing Summary
Sherwin-Williams (SHW) reported an insider equity grant. The company’s President & CEO, who is also a director, received 47,630 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. These options expire on October 19, 2035 and vest in three substantially equal annual installments beginning October 20, 2026, pursuant to the 2025 Equity and Incentive Compensation Plan. No open-market stock sales or purchases were reported.
Positive
- None.
Negative
- None.
Insights
Routine CEO option grant; non-cash, neutral impact.
The filing records a grant of 47,630 employee stock options with a strike price of $331.37, awarded on October 20, 2025 under the 2025 Equity and Incentive Compensation Plan. Options vest in three substantially equal tranches starting October 20, 2026 and expire on October 19, 2035.
This is standard executive compensation and does not involve an immediate share issuance or cash movement. Any eventual share delivery would depend on future vesting and exercise decisions.
No open‑market transactions were disclosed in this report. Future ownership changes, if any, would occur upon vesting and exercise under plan terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 47,630 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options were granted on October 20, 2025, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions.
FAQ
What did Sherwin-Williams (SHW) report in this Form 4?
What is the exercise price of the SHW options granted?
How do the SHW CEO’s options vest?
When do these Sherwin-Williams options expire?
Under which plan were the SHW options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.